Taurine for Longevity: Animal Data vs Human Trials
Taurine's 2023 Science paper was mostly animal work; a 2026 meta-analysis of 34 human RCTs found lower glucose and triglycerides. Evidence and cost.
Researched from published studies and manufacturer specifications, checked .
We have not tested products ourselves. How we research
Quick verdict
Taurine's anti-aging headline comes from animals, and its premise that taurine falls with age was contested in 2025 by two human studies. In humans, a 2026 meta-analysis of 34 RCTs found lower fasting glucose, HbA1c and triglycerides, which are markers rather than outcomes. No human trial shows longer life. At about 5 cents a gram it is cheap; the open question is benefit.
Talk to your doctor first. This is general information, not medical advice. Supplements and devices can interact with medicines and health conditions. We quote study protocols for context and do not recommend doses.
The short answer: taurine’s anti-aging reputation comes from animal studies. A 2023 Science paper found that raising taurine increased health span in mice and monkeys and lifespan in mice. In people, a 2026 meta-analysis of 34 trials found lower fasting glucose, HbA1c and triglycerides, which are markers, not outcomes. Nothing shows taurine lengthens human life. Talk to your doctor before starting, particularly with diabetes or heart medicines.
What the evidence shows
Grades follow the rubric.
| Question | Grade | Evidence | Limit |
|---|---|---|---|
| Lifespan and health span in animals | Not applicable to humans | Science 2023: circulating taurine declines with age in mice, monkeys and humans; supplementation increased health span in mice and monkeys. Lower taurine in humans correlated with age-related diseases. | Correlation in humans; the authors called for human trials. Columbia University filed provisional patent applications on which the senior author is an inventor. |
| Cardiometabolic markers in people | Emerging | Meta-analysis of 34 RCTs: fasting glucose -5.90 mg/dL, HbA1c -0.21%, HOMA-IR -0.57, triglycerides -14.42 mg/dL, total cholesterol -12.41 (units as reported). | Markers only, no disease outcomes. The review’s subgroup and dose-response analyses reported 1.5 to 3.0 g/day as the range with larger improvements (not a recommendation), and trials of 8 weeks or more did better on glucose and lipids. |
The premise was contested in 2025
The 2023 paper’s starting point was that circulating taurine declines with age and that this deficiency may drive aging. Two 2025 studies contest that premise in people. A National Institute on Aging team, publishing in Science, found circulating taurine increased or stayed unchanged with age in three human cohorts, and also in monkeys and mice, and reported considerable variability in how taurine related to motor function and energy handling; it concluded that a change in taurine is not a universal feature of aging. A separate Aging Cell study of 137 men aged 20 to 93, both inactive and active, found no association between blood taurine and age, muscle mass, strength, physical performance or mitochondrial function, and said this challenges taurine deficiency as a primary driver of aging in humans. Both measured blood levels; neither tested supplements or lifespan. They weaken the reason to supplement, not the animal result: the 2023 lifespan finding in mice stands as published, and whether raising taurine helps people who are not deficient is untested.
What is known about safety
A 2008 risk assessment of published human trials found no systematic pattern of adverse effects and called the evidence strong for the absence of harm at supplemental intakes up to 3 g a day in healthy adults (its “observed safe level”), adding that data above that were not enough for a confident long-term conclusion. Its authors are at the Council for Responsible Nutrition, a supplement industry group. It is a review of published trials in healthy adults, not a recommendation, and it says nothing about interactions with diabetes or heart medicines, which is why the doctor boundary above stands.
Cost per gram
Cost per gram lets you price any amount you read about. Prices are one-time list prices from brand pages (re-read 29 Sept 2026), USD, before tax and shipping; arithmetic ours.
| Product | Price | Grams of taurine | Per gram | Per month at 3 g/day (top of the review’s range) |
|---|---|---|---|---|
| Nutricost capsules, 400 x 1,000 mg | $21.97 | 400 | $0.055 | $4.94 |
| Bulk Supplements powder, 500 g | $24.97 | 500 | $0.050 | $4.49 |
| Double Wood capsules, 90 x 1,000 mg | $19.95 | 90 | $0.222 | $19.95 |
The month column uses 3 g/day, the upper end of the range the 2026 meta-analysis reported (not a dose recommendation). At 1.5 g/day, the lower end, halve the figures. Bulk Supplements states no testing; Nutricost and Double Wood print generic claims with no certifier (see what third-party testing means).
What it costs at a trial dose
From our cost per study dose dataset: brand pages, 28 Sept 2026 (Nutricost and Double Wood prices re-checked 29 Sept 2026, unchanged), USD, at 1.5 g/day (the lower bound of the review’s 1.5 to 3.0 g range; double it for 3 g), before tax and shipping.
| Product | Price | Per month at 1.5 g/day | Testing stated |
|---|---|---|---|
| Nutricost Taurine Capsules 1,000 mg, 400 ct | $21.97 | $2.47 | generic third-party claim, certifier not named |
| Double Wood L-Taurine 1,000 mg | $19.95 | $9.97 | self-stated, no named certifier |
| Bulk Supplements Taurine Powder, 500 g | $24.97 | not calculated | none stated |
Taurine is cheap; the open question is benefit, not price. Where it sits: graded supplement ladder. Related: glycine and other amino acids in the cost table, the complete longevity stack, and the longevity biomarkers guide for the glucose and lipid markers those trials measured.
Method note
Researched from PubMed abstract records (29 Sept 2026) and brand pages (28 Sept 2026; Nutricost and Double Wood prices re-checked 29 Sept 2026, unchanged). Abstracts only; grades are our judgement using the published rubric. We did not test any product. General information, not medical advice: this page gives no personal dose.
Common questions
Does taurine extend lifespan in humans?
No human trial shows that. The 2023 Science paper found taurine levels decline with age in mice, monkeys and humans, and that supplementation increased health span and lifespan in mice and health span in monkeys. The authors said human trials seem warranted.
What did human trials find?
A 2026 meta-analysis of 34 randomised trials found taurine supplementation lowered fasting blood glucose (mean difference -5.90 mg/dL), HbA1c (-0.21%), fasting insulin, insulin resistance and triglycerides. These are risk markers, not disease outcomes.
Sources
- Taurine deficiency as a driver of aging (Science 2023) checked 29 Sept 2026
- Oral taurine and cardiometabolic risk factors, meta-analysis of RCTs (Nutr Rev 2026) checked 29 Sept 2026
- Is taurine an aging biomarker? (Fernandez et al., NIA, Science 2025) checked 29 Sept 2026
- Experimental evidence against taurine deficiency as a driver of aging in humans (Aging Cell 2025) checked 29 Sept 2026
- Risk assessment for the amino acids taurine, L-glutamine and L-arginine (Shao and Hathcock, Regul Toxicol Pharmacol 2008) checked 29 Sept 2026
- Bulk Supplements, taurine powder (500 g, $24.97 one-time; no testing statement) checked 29 Sept 2026
- Longevity Intel cost per study dose dataset (prices checked 2026-09-28; Nutricost and Double Wood re-checked 2026-09-29) checked 29 Sept 2026
Update log
- Independent audit against the PubMed abstracts and brand pages: corrected the description of the meta-analysis dose range (a subgroup finding, not the range of doses trialled), the patent disclosure, and the two 2025 studies' findings; noted that the 2008 safety review's authors sit at a supplement industry group.
- Added the two 2025 studies that contest the premise that taurine falls with age, a safety-review paragraph and a cost-per-gram table.
- Price re-check: Nutricost and Double Wood prices re-checked 29 Sept 2026, unchanged.
- Sourcing pass: replaced unsourced claims with the 2023 Science paper (mostly mice, monkeys and worms) and the 2026 meta-analysis of 34 human RCTs; removed dose advice and unverified product claims.
Data and comparisons
- Cardio Modalities Compared: Run vs bike vs row vs swim
Stack modalities
Related reading

NAD+ Boosters: What Human Trials Show
NAD+ precursors (NMN, NR) and IV NAD+ vs the human evidence: blood levels rise, functional results are mixed, IV NAD+ has no anti-aging outcome trials.
Longevity Supplements With Null Trials: Evidence Ledger
Longevity supplements where the best human trials found no benefit: the claim, the strongest trial or review, the result and a grade for each.

Creatine for Longevity: Evidence, Forms, Cost
Creatine monohydrate from meta-analyses: muscle, memory and bone in older adults, kidney and hair concerns, and monthly cost at a trial dose.

Curcumin: Arthritis Trials, Not Longevity
Curcumin: a meta-analysis of 29 RCTs found improved pain and inflammation in arthritis, with low-quality trials; no evidence it extends life.
Glycine for Sleep: What the Trials Show and What It Costs
Glycine before bed: the small trials behind the claim, their sample sizes and funding ties, the dose they used, and a cost check against Thorne's price.